First Time Loading...

EBOS Group Ltd
NZX:EBO

Watchlist Manager
EBOS Group Ltd Logo
EBOS Group Ltd
NZX:EBO
Watchlist
Price: 35.45 NZD 1.9% Market Closed
Updated: Apr 24, 2024

Intrinsic Value

EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. [ Read More ]

The intrinsic value of one EBO stock under the Base Case scenario is 57.88 NZD. Compared to the current market price of 35.45 NZD, EBOS Group Ltd is Undervalued by 39%.

Key Points:
EBO Intrinsic Value
Base Case
57.88 NZD
Undervaluation 39%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
EBOS Group Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling EBO stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
EBOS Group Ltd

Provide an overview of the primary business activities
of EBOS Group Ltd.

What unique competitive advantages
does EBOS Group Ltd hold over its rivals?

What risks and challenges
does EBOS Group Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for EBOS Group Ltd.

Provide P/S
for EBOS Group Ltd.

Provide P/E
for EBOS Group Ltd.

Provide P/OCF
for EBOS Group Ltd.

Provide P/FCFE
for EBOS Group Ltd.

Provide P/B
for EBOS Group Ltd.

Provide EV/S
for EBOS Group Ltd.

Provide EV/GP
for EBOS Group Ltd.

Provide EV/EBITDA
for EBOS Group Ltd.

Provide EV/EBIT
for EBOS Group Ltd.

Provide EV/OCF
for EBOS Group Ltd.

Provide EV/FCFF
for EBOS Group Ltd.

Provide EV/IC
for EBOS Group Ltd.

Show me price targets
for EBOS Group Ltd made by professional analysts.

What are the Revenue projections
for EBOS Group Ltd?

How accurate were the past Revenue estimates
for EBOS Group Ltd?

What are the Net Income projections
for EBOS Group Ltd?

How accurate were the past Net Income estimates
for EBOS Group Ltd?

What are the EPS projections
for EBOS Group Ltd?

How accurate were the past EPS estimates
for EBOS Group Ltd?

What are the EBIT projections
for EBOS Group Ltd?

How accurate were the past EBIT estimates
for EBOS Group Ltd?

Compare the revenue forecasts
for EBOS Group Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of EBOS Group Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of EBOS Group Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of EBOS Group Ltd compared to its peers.

Compare the P/E ratios
of EBOS Group Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing EBOS Group Ltd with its peers.

Analyze the financial leverage
of EBOS Group Ltd compared to its main competitors.

Show all profitability ratios
for EBOS Group Ltd.

Provide ROE
for EBOS Group Ltd.

Provide ROA
for EBOS Group Ltd.

Provide ROIC
for EBOS Group Ltd.

Provide ROCE
for EBOS Group Ltd.

Provide Gross Margin
for EBOS Group Ltd.

Provide Operating Margin
for EBOS Group Ltd.

Provide Net Margin
for EBOS Group Ltd.

Provide FCF Margin
for EBOS Group Ltd.

Show all solvency ratios
for EBOS Group Ltd.

Provide D/E Ratio
for EBOS Group Ltd.

Provide D/A Ratio
for EBOS Group Ltd.

Provide Interest Coverage Ratio
for EBOS Group Ltd.

Provide Altman Z-Score Ratio
for EBOS Group Ltd.

Provide Quick Ratio
for EBOS Group Ltd.

Provide Current Ratio
for EBOS Group Ltd.

Provide Cash Ratio
for EBOS Group Ltd.

What is the historical Revenue growth
over the last 5 years for EBOS Group Ltd?

What is the historical Net Income growth
over the last 5 years for EBOS Group Ltd?

What is the current Free Cash Flow
of EBOS Group Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for EBOS Group Ltd.

Financials

Balance Sheet Decomposition
EBOS Group Ltd

Current Assets 3.3B
Cash & Short-Term Investments 365.3m
Receivables 1.5B
Other Current Assets 1.4B
Non-Current Assets 3.6B
Long-Term Investments 75.9m
PP&E 781.5m
Intangibles 2.6B
Other Non-Current Assets 225.8m
Current Liabilities 2.7B
Accounts Payable 2.3B
Accrued Liabilities 70.3m
Other Current Liabilities 242.3m
Non-Current Liabilities 1.9B
Long-Term Debt 1.6B
Other Non-Current Liabilities 309.9m
Efficiency

Earnings Waterfall
EBOS Group Ltd

Revenue
12.7B AUD
Cost of Revenue
-11.1B AUD
Gross Profit
1.6B AUD
Operating Expenses
-1.1B AUD
Operating Income
464.6m AUD
Other Expenses
-207.2m AUD
Net Income
257.4m AUD

Free Cash Flow Analysis
EBOS Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

EBO Profitability Score
Profitability Due Diligence

EBOS Group Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive 3-Years Revenue Growth
Positive 3-Year Average ROE
Positive Free Cash Flow
Positive 1-Year Revenue Growth
50/100
Profitability
Score

EBOS Group Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

EBO Solvency Score
Solvency Due Diligence

EBOS Group Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
41/100
Solvency
Score

EBOS Group Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EBO Price Targets Summary
EBOS Group Ltd

Wall Street analysts forecast EBO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EBO is 39.74 NZD with a low forecast of 35.33 NZD and a high forecast of 43.62 NZD.

Lowest
Price Target
35.33 NZD
0% Downside
Average
Price Target
39.74 NZD
12% Upside
Highest
Price Target
43.62 NZD
23% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

EBO Price
EBOS Group Ltd

1M 1M
+3%
6M 6M
+3%
1Y 1Y
-22%
3Y 3Y
+27%
5Y 5Y
+77%
10Y 10Y
+385%
Annual Price Range
35.45
52w Low
33.85
52w High
45.7
Price Metrics
Average Annual Return 23.86%
Standard Deviation of Annual Returns 17.87%
Max Drawdown -27%
Shares Statistics
Market Capitalization 6.8B NZD
Shares Outstanding 193 228 000
Percentage of Shares Shorted
N/A

EBO Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

EBOS Group Ltd Logo
EBOS Group Ltd

Country

New Zealand

Industry

Health Care

Market Cap

6.8B NZD

Dividend Yield

3.28%

Description

EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. The firm is also an animal care products marketer and distributor. Its segments include Healthcare, Animal care and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, own brands, retail healthcare, wholesale activities and logistics. The Animal care segment incorporates the sale of animal care products in a range of sectors, own brands, retail and wholesale activities. Its businesses include Community Pharmacy, Institutional Healthcare, Contract Logistics and Animal Care. Community Pharmacy includes Symbion, Endeavour Consumer Health, ProPharma, DoseAid and Intellipharm. Institutional Healthcare includes EBOS Healthcare, Onelink, Clinect and Zest. Contract Logistics comprises Healthcare Logistics, Symbion Contract Logistics and Symbion Clinical Trials. Animal Care includes Masterpet, Lyppard, Animates and Vitapet.

Contact

CHRISTCHURCH
108 Wrights Road
+6433380999.0
http://www.ebosgroup.com/

IPO

1986-06-16

Employees

-

Officers

Chief Executive Officer
Mr. John Cullity
CFO & Chief Accountant
Mr. Leonard Hansen
Chief Information Officer
Mithran Naiker
General Counsel
Ms. Janelle Cain
Group General Manager of Human Resources
Ms. Jacinta McCarthy
Executive General Manager of Strategic Operations, ESG & Innovation
Mr. Simon Bunde
Show More
Chief Executive Officer of Animal Care
Ms. Julie Dillon
Chief Executive Officer of Medical Technology
Mr. Matthew Muscio
Chief Executive Officer of Symbion
Mr. Brett Barons
Show Less

See Also

Discover More
What is the Intrinsic Value of one EBO stock?

The intrinsic value of one EBO stock under the Base Case scenario is 57.88 NZD.

Is EBO stock undervalued or overvalued?

Compared to the current market price of 35.45 NZD, EBOS Group Ltd is Undervalued by 39%.